A detailed history of Ewa, LLC transactions in Renalytix PLC stock. As of the latest transaction made, Ewa, LLC holds 16,486 shares of RNLX stock, worth $2,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,486
Previous 28,374 41.9%
Holding current value
$2,472
Previous $17.5 Million 71.15%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$0.23 - $0.93 $2,734 - $11,055
-11,888 Reduced 41.9%
16,486 $5.05 Million
Q1 2024

May 13, 2024

SELL
$0.26 - $1.47 $1,582 - $8,949
-6,088 Reduced 17.67%
28,374 $17.5 Million
Q4 2023

Feb 05, 2024

BUY
$0.33 - $1.61 $11,372 - $55,483
34,462 New
34,462 $10.8 Million

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Ewa, LLC Portfolio

Follow Ewa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.